130 likes | 358 Views
Access to transplant in the UK. Unexplained between centre variation in access to the waiting list, time taken for activation and receipt of a transplant once activated*Patient and/or unit specific variables that explain such variation not clear. * BMJ 2010;341:c3451. Percentage listed prior to s
E N D
1. Access to transplant in the UKThe ATTOM study Dr Rommel Ravanan
Rommel.ravanan@nbt.nhs.uk
On behalf of ATTOM investigators
2. Access to transplant in the UK Unexplained between centre variation in access to the waiting list, time taken for activation and receipt of a transplant once activated*
Patient and/or unit specific variables that explain such variation not clear
7. The questionnaire looked at various aspect of transplant assessment.
We looked at organisation of assessment clinics and unit protocols.
Additional Consultations and baseline investigations performed
Any important aspect section addressed the issue of cardiovascular assessment. We also looked at serological investigations, gastrointestinal evaluation; exclusion criteria based on age and BMI and last but not the least the unit’s Re-evaluation policy once patients are on the waiting list.The questionnaire looked at various aspect of transplant assessment.
We looked at organisation of assessment clinics and unit protocols.
Additional Consultations and baseline investigations performed
Any important aspect section addressed the issue of cardiovascular assessment. We also looked at serological investigations, gastrointestinal evaluation; exclusion criteria based on age and BMI and last but not the least the unit’s Re-evaluation policy once patients are on the waiting list.
8. The ATTOM group
Cambridge Bristol
Andrew Bradley Charlie Tomson
Chris Watson Chris Dudley
Ms Ruth Summers (NHS manager) Rommel Ravanan
Edinburgh UKRR
Gabriel Oniscu Terry Feest / Damian Fogarty
John Forsythe
SRR NHSBT
Wendy Metcalfe Rachel Johnson
Royal Holloway LSHTM
Prof Clare Bradley (PROMs expertise) Prof John Cairns (Health economic expertise)
Southampton University (Epidemiology & Qualitative research expertise)
Prof Paul Roderick,
Dr Gerry Leydon
+ Ethics & patients representatives
11. ATTOM - how Embedded research nurses in 20 transplant centres
Nurses record clinical phenotype from case notes/IT systems
Administer/collect PROMs questionnaires
Parallel qualitative assessment of centre practice patterns
Outcome data by linking ATTOM database to registries
12. ATTOM – help needed Local PIs for R&D approvals (~May 2011)
Facilitate local nurse recruitment (~August/September 2011)
Data clarifications (if needed) for nurses
Participate in semi-structured interviews / answer questionnaires (for the qualitative work stream)
13. ATTOM - output What’s in it for the units?
Accurate benchmarking of unit level co-morbidity burden / transplant related resource availability
Share ‘best practice’
‘Free’ near complete data returns to UKRR/SRR
NIHR portfolio income to your NHS trust
What’s in it for the renal community in the UK?
‘Real world’ UK clinical evidence base to drive UK clinical policy
Survival probability model to improve equity of access
Understanding PROMs in renal patients
Permanent complete dataset for many analyses by UKRR/SRR
14. Contact for information
Rommel.ravanan@nbt.nhs.uk
Charlie.tomson@nbt.nhs.uk